Profile picture

Doctor Nora Wainstejn

German Heart Institute Berlin, Berlin (Germany)
Membership: EHRA Member
Follow
Biography
Nora Wainstejn is a fellow in electrophysiology and device therapy with a particular clinical and scientific interest in device therapy, electrophysiology, and sudden cardiac death. Her interest in electrophysiology began in 2015 through early exposure to the EP laboratory during medical school. She concluded the Biotronik BEEP Fellowship in 2024 and completed the theoretical part of the EHRA Examination in devices in 2024. Her work focuses on the clinical management and research of sudden cardiac death, with special emphasis on device-based strategies. She is fluent in english and also has basic knowledge of Swedish from an Erasmus stay begun in 2016. Outside her professional activities, she enjoys beach volleyball.
Logo ESC

Contributor content

Low-Voltage areas in women with atrial fibrillation: Implications for tailored ablation strategies
Presentation
Low-Voltage areas in women with atrial fibrillation: Implications for tailored ablation strategies
Refined diagnostic understanding of arrhythmogenic cardiomyopathy in the modern era from overdiagnosis to diagnostic precision: the evolving diagnostic criteria for arrhythmogenic cardiomyopathy
Presentation
Refined diagnostic understanding of arrhythmogenic cardiomyopathy in the modern era from overdiagnosis to diagnostic precision: the evolving diagnostic criteria for arrhythmogenic cardiomyopathy
When myocardial fibrosis silences the signal: lessons from desmoplakin cardiomyopathy
Presentation
When myocardial fibrosis silences the signal: lessons from desmoplakin cardiomyopathy
Sex differences in patients undergoing pulmonary vein isolation with high power short duration ablation and CLOSE protocol
Presentation
Sex differences in patients undergoing pulmonary vein isolation with high power short duration ablation and CLOSE protocol
Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.
Presentation
Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.
Single procedure outcome in patients with atrial fibrillation and reduced ejection fraction after pulmonary vein isolation using the second-generation 28mm cryoballoon
Presentation
Single procedure outcome in patients with atrial fibrillation and reduced ejection fraction after pulmonary vein isolation using the second-generation 28mm cryoballoon

ESC 365 is supported by